Romero J et al. |
Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study. |
2002 |
Brain Res. Mol. Brain Res. |
pmid:12008024
|
Kozak KR et al. |
15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist. |
2002 |
J. Biol. Chem. |
pmid:11956198
|
Bisogno T et al. |
Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications. |
2002 |
Curr. Pharm. Des. |
pmid:11945157
|
Sugiura T and Waku K |
2-arachidonoylglycerol: an endogenous cannabinoid receptor agonist. |
2001 |
World Rev Nutr Diet |
pmid:11935957
|
Jordà MA et al. |
Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol. |
2002 |
Blood |
pmid:11929767
|
Mechoulam R et al. |
Cannabinoids and brain injury: therapeutic implications. |
2002 |
Trends Mol Med |
pmid:11815270
|
Darmani NA |
The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids. |
2002 |
J. Pharmacol. Exp. Ther. |
pmid:11752094
|
Al-Hayani A et al. |
The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. |
2001 |
Neuropharmacology |
pmid:11747904
|
Wagner JA et al. |
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. |
2001 |
J. Am. Coll. Cardiol. |
pmid:11738314
|
van der Stelt M et al. |
Exogenous anandamide protects rat brain against acute neuronal injury in vivo. |
2001 |
J. Neurosci. |
pmid:11698588
|
Kurihara J et al. |
2-Arachidonoylglycerol and anandamide oppositely modulate norepinephrine release from the rat heart sympathetic nerves. |
2001 |
Jpn. J. Pharmacol. |
pmid:11676206
|
Berdyshev EV et al. |
Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. |
2001 |
FASEB J. |
pmid:11641243
|
Savinainen JR et al. |
Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes. |
2001 |
Br. J. Pharmacol. |
pmid:11588122
|
Panikashvili D et al. |
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. |
2001 |
Nature |
pmid:11586361
|
Fowler CJ et al. |
Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide. |
2001 |
Biochem. Pharmacol. |
pmid:11585048
|
Hansen HH et al. |
Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. |
2001 |
J. Neurochem. |
pmid:11579150
|
Stella N and Piomelli D |
Receptor-dependent formation of endogenous cannabinoids in cortical neurons. |
2001 |
Eur. J. Pharmacol. |
pmid:11513837
|
Di Marzo V et al. |
Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells. |
2001 |
Biochem. J. |
pmid:11485574
|
Yamaguchi T et al. |
Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice. |
2001 |
Brain Res. |
pmid:11478928
|
Maccarrone M et al. |
Anandamide degradation and N-acylethanolamines level in wild-type and CB1 cannabinoid receptor knockout mice of different ages. |
2001 |
J. Neurochem. |
pmid:11461969
|